V, R., A, S., J, Z., B, A., VA, T., J, J., . . . A, N. (2022). Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer, 128(18), 3383. https://doi.org/10.1002/cncr.34370
Chicago Style (17th ed.) CitationV, Ravi, et al. "Clinical Activity of Checkpoint Inhibitors in Angiosarcoma: A Retrospective Cohort Study." Cancer 128, no. 18 (2022): 3383. https://doi.org/10.1002/cncr.34370.
MLA (9th ed.) CitationV, Ravi, et al. "Clinical Activity of Checkpoint Inhibitors in Angiosarcoma: A Retrospective Cohort Study." Cancer, vol. 128, no. 18, 2022, p. 3383, https://doi.org/10.1002/cncr.34370.
Warning: These citations may not always be 100% accurate.